Hypothesis
The inner ear endothelium is capable of responding to therapeutic steroids by altering local expression of cytokine and ion homeostasis genes that impact inflammation and fluid regulation.
Background
Glucocorticoids are often given trans-tympanically for hearing disorders because of their anti-inflammatory effects, but their direct impact on inner ear ion homeostasis and cytokine gene expression has not been studied.
Methods
The middle ears of Balb/c mice were transtympanically injected with 5 µl of either phosphate-buffered saline (PBS), prednisolone or dexamethasone. Untreated mice were used as controls. Mice were euthanized at 6, 24 and 72 hours, the cochleas harvested and total RNA isolated from the inner ear tissues. Expression of eight cytokine genes and 24 ion homeostasis genes were analyzed with qRT-PCR.
Results
PBS caused upregulation of inflammatory cytokine genes that peaked at 6 hours. Surprisingly, prednisolone and dexamethasone also caused upregulation of most cytokine genes. Interestingly, ion homeostasis genes were predominantly upregulated with dexamethasone and prednisolone, with prednisolone having the larger effect.
Conclusion
In the murine model, intratympanic steroids caused an initial upregulation of inflammatory cytokine genes in the inner ear, as well as predominantly upregulation of ion homeostasis genes. These findings suggest glucorticoids do not suppress inner ear inflammation, but rather cause an initial inflammatory response in the inner ear. Thus, inflammatory gene suppression is not a likely mechanism for their hearing restorative effects. On the other hand, these steroids have a significant mineralocorticoid function, as demonstrated by increased function of ion homeostasis genes, implicating their ionic and fluid regulatory properties as a mechanism for their therapeutic effects.